টাইটেলঃ Advances in Stem Cell Research 2015
তারিখঃ ১৮ নভেম্বর, বুধবার
মাধ্যমঃ পারসোনাল পিসি/ল্যাপটপ/মোবাইল
Benefits of attending this Virtual Event:
Opportunity to view posters, including an
interactive session with the poster
presenters.
Access to a virtual exhibit hall, enabling
you to catch up with the latest
technological developments in the industry
via video, downloadable applications,
brochures and interaction with booth staff.
View others in attendance and chat with
them privately or in open forums.
অ্যাজেন্ডাঃ টাইমস আর ইন ব্রিটিস স্ট্যান্ডার্ড টাইম
09:00 Title To Be Confirmed
Mikael Kubista, Professor/Founder,
TATAA Biocenter AB
10:00 Keynote Presentation
Confirming the Origin
of Stem Cells
John Masters ,
Professor, University
College London
The donor of origin
of a stem cell culture
must be confirmed
using STR profiling
for quality control
purposes.
11:00 Small Molecule-Directed High
Efficient Conversion of Pluripotent
Human Embryonic Stem Cells into
Functional Human Neuronal or
Cardiomyocyte Cell Therapy
Derivatives for Regenerative Medicine
Xuejun Parsons , Associate Professor,
San Diego Regenerative Medicine
Institute
Transforming non-functional
pluripotent human embryonic stem
cells into fate-restricted functional
human neuronal or cardiomyocyte
cell therapy derivatives by small
molecule-directed induction
overcomes some major obstacles in
moving stem cell research from
animals towards human trials.
12:00 Networking in Exhibition Hall
13:00 Identification of Genetic Modifiers of
Leukemic Stem Cell Pathophysiology
Gregor Adams , Assistant Professor,
University of Southern California
Cancer is a result of complex
interactions between germline
genetic susceptibility, oncogenic
somatic mutations, and
environmental insults. We are using
an innovative genome-wide
association study approach in mice
to identify the genetic factors
controlling leukemic stem cell
pathophysiology.
14:00 Commercialization and Manufacturing
Devyn Smith, Head of Strategy, R&D
Division, Pfizer
How does manufacturing impact the
success of a product?
15:00 The Why and How of Foreign
Companies Advancing Cell Therapies
in Japan
Lee Buckler , Founder & Managing
Director, Cell Therapy Group
Recent changes to Japan’s
regenerative medicine regulatory
policy around oversight, approval,
clinical development and
manufacturing processes related to
cell-based therapies has established
Japan as a leader in the regenerative
medicine industry and is enticing
foreign companies to develop
products in Japan. Only a handful of
companies have created formal ties
with Japanese industry to leverage
this rapidly emerging opportunity –
RepliCel Life Sciences Inc. being one
of them.
16:00 Moringa Root Extract May Kill
Ovarian Cancer Stem Cell through
FSHR, a Co-expressed Stem Cell
Marker of Such Cancer
Chinmoy K Bose , Consultant Gyn
Oncologist, Kolkata Municipal
Corporation
In a recent cell culture study we have
detected considerably significant
apoptotic activity of moringa root
water extract in ovarian cancer cell
line.
ডিটেলস জানতে এখানেক্লিক করুন
যোগাযোগ: শুভাশিস সাহা শুভ
পরিমার্জনা: বনফুল
